Disc Medicine (IRON) Profit After Tax (2020 - 2026)
Disc Medicine's (IRON) quarterly Profit After Tax came in at -$63.5 million in Q1 2026, down 86.31% year-on-year from -$463.9 million in Q1 2025, and down 4.91% on a QoQ basis from -$60.5 million in Q4 2025.
Disc Medicine (IRON) Profit After Tax (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Profit After Tax data on file, last reported at -$63.5 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 86.31% year-over-year to -$63.5 million in Q1 2026; TTM through Mar 2026 was -$241.6 million, a 107.4% decrease from a year earlier, with the FY2025 full-year figure at -$212.2 million, down 94.03% from the prior year.
- Profit After Tax for Q1 2026 stood at -$63.5 million, down from -$60.5 million in the prior quarter.
- Over the last five years, Profit After Tax for IRON reached as high as -$9.6 million in Q2 2022 and fell as low as -$63.5 million in Q1 2026.
- Historically, Profit After Tax has averaged -$29.9 million across 5 years, with a median of -$26.4 million in 2024.
- On a YoY basis, Profit After Tax climbed as much as 48.27% in 2022 and fell as far as 162.2% in 2022.
- Year by year, Profit After Tax stood at -$11.2 million in 2022, then plunged by 109.7% to -$23.6 million in 2023, then fell by 24.93% to -$29.5 million in 2024, then sank by 105.49% to -$60.5 million in 2025, then dropped by 4.91% to -$63.5 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$63.5 million in Q1 2026, -$60.5 million in Q4 2025, and -$62.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | -63.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.50 Mn |
| Dec 31, 2025 | -60.53 Mn |
| Sep 30, 2025 | -62.32 Mn |
| Jun 30, 2025 | -55.25 Mn |
| Mar 31, 2025 | -34.09 Mn |
| Dec 31, 2024 | -29.46 Mn |
| Sep 30, 2024 | -26.60 Mn |
| Jun 30, 2024 | -26.35 Mn |
| Mar 31, 2024 | -26.95 Mn |
| Dec 31, 2023 | -23.58 Mn |
| Sep 30, 2023 | -14.12 Mn |
| Jun 30, 2023 | -15.95 Mn |
| Mar 31, 2023 | -22.78 Mn |
| Dec 31, 2022 | -11.24 Mn |
| Sep 30, 2022 | -16.15 Mn |
| Jun 30, 2022 | -9.58 Mn |
| Mar 31, 2022 | -9.85 Mn |
| Dec 31, 2021 | 18.08 Mn |
| Sep 30, 2021 | -18.55 Mn |
| Jun 30, 2021 | -16.45 Mn |